Skip to main content
High RiskFDAfda-F-1656-2018UNDECLARED ALLERGEN

Odwalla Superfood fruit smoothie 15.2 oz. (450mL) plastic bottle; Sold in 8 pack case Unit UPC: 000-14054-06405-5 Odwalla Life Food-...

Category
Units Affected
14,870
Recall Date
July 13, 2018
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1656-2018.

There is the potential for a limited quantity of bottles to contain foreign matter in the form of tiny pieces of wire metal fragments.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1656-2018.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact The Coca-cola Company or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1656-2018.

The Coca-Cola Company

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

The Coca-cola Company Recall FAQ

The Coca-cola Company is the subject of a beverages safety report: Odwalla Superfood fruit smoothie 15.2 oz. (450mL) plastic bottle; Sold in 8 pack case Unit UPC: 000-14054-06405-5 Odwalla Life Food-.... The notice was published on July 13, 2018 by the U.S. Food and Drug Administration (FDA). Approximately 14,870 units are potentially affected.